StockSelector.com
  Research, Select, & Monitor Sunday, July 22, 2018 10:38:25 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ligand Pharmaceuticals, Inc.$231.88($.66)(.28%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ligand Pharmaceuticals, Inc. has an overall rank of 404 out of 7039 stocks based on 14 positive rankings and 5 negative rankings.

Positive Rankings
Highest Net Margin
Ligand Pharmaceuticals rank is 159
Estimated EPS Growth
Ligand Pharmaceuticals rank is 257
Low Put/Call
Ligand Pharmaceuticals has a low Put/Call ratio of 0.13 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Ligand Pharmaceuticals is ranked 266.
Historic Revenue Growth
Ligand Pharmaceuticals rank is 329
10 Day Gain
Ligand Pharmaceuticals rank is 394
Estimated Revenue Growth
Ligand Pharmaceuticals rank is 417
90 Day Gain
Ligand Pharmaceuticals rank is 463
Target Prices
The average analysts' target price is $260.00 for Ligand Pharmaceuticals using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Ligand Pharmaceuticals is ranked 505.
Top Industry Values
Ligand Pharmaceuticals rank is 668
Up EPS Surprise
Ligand Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
Highest Cash Growth
Ligand Pharmaceuticals rank is 1168
Debt-to-Equity
Ligand Pharmaceuticals rank is 1395
Highest ROA
Ligand Pharmaceuticals rank is 2345
Highest ROE
Ligand Pharmaceuticals rank is 2849
Negative Rankings
Overbought RSI
The 14 Day Relative-Strength Index for Ligand Pharmaceuticals is 75.0. An RSI above 70 indicates the stock is overbought. Among companies with a high RSI, Ligand Pharmaceuticals is ranked 106.
Price-to-Sales
Ligand Pharmaceuticals rank is 222
Price-to-Book
Ligand Pharmaceuticals rank is 348
Overbought Stochastics
Ligand Pharmaceuticals rank is 562
High vPut/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 0.64 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 1266.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.